Sanofi | SAN - Cash And Equivalent


Sanofi reported EUR6.35B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
AbbVie USD 10.77B 4.2B Sep/2026
Aena EUR 1.39B 1.56B Jun/2026
Alcon AG USD 1.36B 223M Jun/2026
Almirall EUR 354.57M 16.8M Jun/2026
Amarin USD 156.51M 12.95M Sep/2026
Amgen USD 13.19B 799M Sep/2026
AstraZeneca USD 4.89B 2.67B Jun/2026
Bayer EUR 4.29B 1.44B Jun/2026
Biogen USD 1.3B 18.9M Sep/2026
BMW EUR 18.5B 516M Jun/2026
Bristol-Myers Squibb USD 9.57B 852M Sep/2026
Eli Lilly USD 4.89B 4.07B Sep/2026
Essilor EUR 1.93B 1.61B Jun/2026
Fresenius EUR 1.28B 780M Jun/2026
Fresenius Medical Care EUR 1.1B 37.86M Sep/2026
Genmab DKK 1.5B 18M Jun/2026
Gilead Sciences USD 3.18B 4.45B Jun/2026
GlaxoSmithKline GBP 3.1B 337M Jun/2026
GRIFOLS EUR 486M 27M Sep/2026
Hikma Pharmaceutical USD 217M 19M Dec/2025
J&J USD 16.91B 3.51B Sep/2026
Lakefront Biotherapeutics EUR 135.95M 69.15M Jun/2026
Lonza CHF 719M 188M Dec/2025
Mercedes-Benz AG EUR 10.14B 2.06B Jun/2026
Merck EUR 2.74B 415M Mar/2026
Merck USD 9.55B 2.7B Sep/2026
Novartis USD 8.87B 1.25B Sep/2026
Novo Nordisk A/S DKK 18.44B 5.78B Jun/2025
Orion EUR 144.3M 55M Sep/2026
Pfizer USD 1.82B 848M Sep/2026
Philips EUR 2.75B 962M Sep/2026
Recordati EUR 391.38M 10.92M Jun/2026
Regeneron Pharmaceuticals USD 3.66B 1.2B Sep/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 6.35B 806M Jun/2026
Sanofi EUR 6.35B 806M Jun/2026
SAP EUR 9.36B 1.15B Sep/2026
UCB EUR 1.57B 1.14B Dec/2024
Vinci EUR 17.25B 2.18B Dec/2025
Volkswagen EUR 48.12B 9.32B Mar/2026